Morand Piert

597 total citations
18 papers, 447 citations indexed

About

Morand Piert is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Morand Piert has authored 18 papers receiving a total of 447 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Radiology, Nuclear Medicine and Imaging, 10 papers in Pulmonary and Respiratory Medicine and 3 papers in Surgery. Recurrent topics in Morand Piert's work include Prostate Cancer Treatment and Research (5 papers), Medical Imaging Techniques and Applications (4 papers) and Prostate Cancer Diagnosis and Treatment (4 papers). Morand Piert is often cited by papers focused on Prostate Cancer Treatment and Research (5 papers), Medical Imaging Techniques and Applications (4 papers) and Prostate Cancer Diagnosis and Treatment (4 papers). Morand Piert collaborates with scholars based in United States, Italy and Germany. Morand Piert's co-authors include Bruno Giordani, D.E. Kuhl, Stanley Berent, Larry Junck, Matthew J. Schipper, Theodore S. Lawrence, Christina Tsien, Yue Cao, Doris Brown and Daniel P. Normolle and has published in prestigious journals such as Clinical Cancer Research, International Journal of Radiation Oncology*Biology*Physics and Journal of Nuclear Medicine.

In The Last Decade

Morand Piert

17 papers receiving 432 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Morand Piert United States 11 180 160 106 70 47 18 447
Kyung‐Han Lee South Korea 8 101 0.6× 94 0.6× 79 0.7× 57 0.8× 27 0.6× 17 409
René Johannes Laursen Denmark 7 71 0.4× 83 0.5× 174 1.6× 76 1.1× 28 0.6× 15 385
Saori Okamoto Japan 11 77 0.4× 75 0.5× 137 1.3× 40 0.6× 55 1.2× 15 399
Octavio Arevalo United States 13 92 0.5× 138 0.9× 170 1.6× 30 0.4× 29 0.6× 43 505
Wolf Müller Germany 14 62 0.3× 84 0.5× 127 1.2× 71 1.0× 30 0.6× 25 444
Franziska Vettermann Germany 13 243 1.4× 70 0.4× 324 3.1× 34 0.5× 33 0.7× 23 539
Franz Marhold Austria 12 72 0.4× 95 0.6× 168 1.6× 46 0.7× 43 0.9× 41 407
Michael J. Moravan United States 10 82 0.5× 297 1.9× 120 1.1× 116 1.7× 17 0.4× 36 632
Gary E. Kraus United States 9 151 0.8× 63 0.4× 163 1.5× 71 1.0× 19 0.4× 22 416
Christina Schaub Germany 15 138 0.8× 157 1.0× 302 2.8× 33 0.5× 32 0.7× 49 713

Countries citing papers authored by Morand Piert

Since Specialization
Citations

This map shows the geographic impact of Morand Piert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Morand Piert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Morand Piert more than expected).

Fields of papers citing papers by Morand Piert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Morand Piert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Morand Piert. The network helps show where Morand Piert may publish in the future.

Co-authorship network of co-authors of Morand Piert

This figure shows the co-authorship network connecting the top 25 collaborators of Morand Piert. A scholar is included among the top collaborators of Morand Piert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Morand Piert. Morand Piert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Edwards, Donna M., Caitlin A. Schonewolf, John D. Rice, et al.. (2024). Phase 2 Trial Assessing Toxicity of Personalized Response-Based Radiation Treatment in Patients With Locally Advanced Non-Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 120(5). 1332–1343.
2.
Ferdinandus, Justin, Wolfgang P. Fendler, Andrea Farolfi, et al.. (2021). PSMA PET Validates Higher Rates of Metastatic Disease for European Association of Urology Biochemical Recurrence Risk Groups: An International Multicenter Study. Journal of Nuclear Medicine. 63(1). 76–80. 24 indexed citations
3.
Aryal, Madhava, Hemant Parmar, Morand Piert, et al.. (2020). A Phase II Study of Dose-Intensified Chemoradiation Using Biologically-Based Target Volume Definition in Patients with Newly Diagnosed Glioblastoma. International Journal of Radiation Oncology*Biology*Physics. 108(3). S20–S20. 4 indexed citations
4.
Lebastchi, Amir H., Nikhil Gupta, John Michael DiBianco, et al.. (2020). Comparison of cross-sectional imaging techniques for the detection of prostate cancer lymph node metastasis: a critical review. Translational Andrology and Urology. 9(3). 1415–1427. 10 indexed citations
5.
Davenport, Matthew S., et al.. (2019). 18F-Choline PET/mpMRI for Detection of Clinically Significant Prostate Cancer: Part 2. Cost-Effectiveness Analysis. Journal of Nuclear Medicine. 60(12). 1705–1712. 11 indexed citations
6.
7.
Piert, Morand, Jeffrey S. Montgomery, Lakshmi P. Kunju, et al.. (2016). 18F-Choline PET/MRI: The Additional Value of PET for MRI-Guided Transrectal Prostate Biopsies. Journal of Nuclear Medicine. 57(7). 1065–1070. 36 indexed citations
8.
Brooks, Allen F., et al.. (2016). [11C]sarcosine for PET imaging of prostate cancer. 57. 1068–1068. 1 indexed citations
9.
Kong, Feng‐Ming, Jianwei Wang, Ka Kit Wong, Morand Piert, & Kirk A. Frey. (2013). Inter-method Comparison and Optimization of [18F] FDG PET Metabolic Response Assessment in Non-Small Cell Lung Cancer. Practical Radiation Oncology. 3(2). S23–S23. 1 indexed citations
10.
Keller, Jill M., George R. Schade, Kimberly Ives, et al.. (2013). A novel canine model for prostate cancer. The Prostate. 73(9). 952–959. 31 indexed citations
11.
Arabi, Mohammad, Richard K. Brown, Ben A. Dwamena, et al.. (2013). Single-Photon Emission Computed Tomography/Computed Tomography as a Problem-Solving Tool in Patients With Suspected Acute Cholecystitis. Journal of Computer Assisted Tomography. 37(6). 844–848. 1 indexed citations
12.
Djekidel, Mehdi, Richard K. Brown, & Morand Piert. (2011). Benefits of Hybrid SPECT/CT for 111In-Oxine- and Tc-99m-Hexamethylpropylene Amine Oxime-Labeled Leukocyte Imaging. Clinical Nuclear Medicine. 36(7). e50–e56. 20 indexed citations
13.
Tsien, Christina, Doris Brown, Daniel P. Normolle, et al.. (2011). Concurrent Temozolomide and Dose-Escalated Intensity-Modulated Radiation Therapy in Newly Diagnosed Glioblastoma. Clinical Cancer Research. 18(1). 273–279. 107 indexed citations
14.
Wong, Ka Kit, et al.. (2008). F-18 FDG PET/CT Study Showing Cervical Extension of Thymic Tissue. Clinical Nuclear Medicine. 33(8). 547–548. 1 indexed citations
15.
Treiber, Uwe, Hubert Kübler, H. Van Randenborgh, et al.. (2005). 633Diagnostic efficacy of 11C-choline positron emission tomography in patients scheduled for cystectomy. European Urology Supplements. 4(3). 161–161. 4 indexed citations
16.
Metz, Stephan, Heike E. Daldrup‐Link, Thomas Richter, et al.. (2003). Detection and Quantification of Breast Tumor Necrosis with MR Imaging. Academic Radiology. 10(5). 484–490. 45 indexed citations
17.
Piert, Morand, et al.. (1996). Diminished glucose transport and phosphorylation in Alzheimer's disease determined by dynamic FDG-PET.. PubMed. 37(2). 201–8. 105 indexed citations
18.
Piert, Morand, Robert A. Koeppe, Bruno Giordani, Satoshi Minoshima, & Dietmar Kuhl. (1996). Determination of regional rate constants from dynamic FDG-PET studies in Parkinson's disease.. PubMed. 37(7). 1115–22. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kyung‐Han Lee Breakdown of academic impact, for papers by René Johannes Laursen Breakdown of academic impact, for papers by Saori Okamoto Breakdown of academic impact, for papers by Octavio Arevalo Breakdown of academic impact, for papers by Wolf Müller Breakdown of academic impact, for papers by Franziska Vettermann Breakdown of academic impact, for papers by Franz Marhold Breakdown of academic impact, for papers by Michael J. Moravan Breakdown of academic impact, for papers by Gary E. Kraus Breakdown of academic impact, for papers by Christina Schaub
Rankless by CCL
2026